Recombinant factor VIIa for variceal bleeding: when, why, and how?

[1]  D. Thabut,et al.  Recombinant factor VIIa for upper gastrointestinal bleeding in patients with cirrhosis: a randomized, double-blind trial. , 2004, Gastroenterology.

[2]  L. Aledort.  Comparative thrombotic event incidence after infusion of recombinant factor VIIa versus factor VIII inhibitor bypass activity , 2004, Journal of thrombosis and haemostasis : JTH.

[3]  F. Pellicer-Bautista,et al.  Refractory Bleeding after Endoscopic Sphincterotomy: A New Indication for Recombinant Factor VII Therapy? , 2004, American Journal of Gastroenterology.

[4]  R. Poupon,et al.  Improved survival after variceal bleeding in patients with cirrhosis over the past two decades , 2004, Hepatology.

[5]  K. Lai,et al.  Are vasoactive drugs truly the treatment of choice for acute esophageal variceal hemorrhage? , 2004, Gastroenterology.

[6]  S. Caldwell,et al.  Recombinant activated factor VII (rFVIIa) as a hemostatic agent in liver disease: A break from convention in need of controlled trials , 2004, Hepatology.

[7]  F. Pellicer-Bautista,et al.  Recombinant-activated factor VII as hemostatic therapy in eight cases of severe hemorrhage from esophageal varices. , 2004, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[8]  L. Fink,et al.  Recombinant factor VIIa in the treatment of bleeding. , 2004, American journal of clinical pathology.

[9]  H. Vilstrup,et al.  Recombinant Activated Factor VII (rFVIIa) Acutely Normalizes Prothrombin Time in Patients with Cirrhosis During Bleeding from Oesophageal Varices , 2001, Scandinavian journal of gastroenterology.

[10]  K. Reddy,et al.  Recombinant factor VIIa corrects prothrombin time in cirrhotic patients: a preliminary study. , 1997, Gastroenterology.

[11]  Goodall Rj.  Bleeding after endoscopic sphincterotomy. , 1985 .